Sale!

Immunosuppressant Drug Profile 2 Test

Original price was: 1,790 د.إ.Current price is: 1,610 د.إ.

-10%

The “Immunosuppressant Drug Profile 2 Test” is a specialized diagnostic assessment conducted at DNA Labs UAE, designed to monitor and evaluate the levels of specific immunosuppressant drugs in the bloodstream. This test is particularly crucial for patients who have undergone organ transplantation or those with autoimmune diseases, as it helps in ensuring that the dosage of immunosuppressant medication is optimal for preventing organ rejection while minimizing potential side effects. The test cost is set at 1610 AED and is performed using advanced laboratory techniques to provide accurate and reliable results. By assessing the concentration of immunosuppressant drugs, healthcare providers can make informed decisions on adjusting medication regimens to achieve the best possible outcomes for their patients.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

IMMUNOSUPPRESSANT DRUG PROFILE 2 Test

Test Name: IMMUNOSUPPRESSANT DRUG PROFILE 2 Test

Test Components: Cyclosporine, Sirolimus

Price: 1610.0 AED

Sample Condition: 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube. Ship refrigerated. Ideal sampling time: Just before the next dose (Trough levels). Provide date & time of sampling, dose taken & time of dosing.

Report Delivery: Sample Daily by 5 pm; Report Same day

Method: LC-MS/MS

Test type: Therapeutic Drug Monitoring

Doctor: Gastroenterologist, Nephrologist

Test Department: GENETIC

Pre Test Information: Provide date & time of sampling, dose taken & time of dosing.

Test Details

Immunosuppressant drugs are medications that suppress or weaken the immune system. They are commonly used in the treatment of autoimmune diseases, organ transplantation, and certain types of cancer. Here is a profile of a specific immunosuppressant drug:

Drug Name: Tacrolimus (Prograf)

Mechanism of Action: Tacrolimus inhibits the activity of T-lymphocytes, a type of white blood cell involved in the immune response. It works by binding to a protein called FK-binding protein-12 (FKBP-12), which inhibits the activation of calcineurin. This prevents the production of interleukin-2 (IL-2), a cytokine that stimulates T-cell proliferation and activation.

Indications: Tacrolimus is primarily used as an immunosuppressant in organ transplantation, particularly for kidney, liver, and heart transplants. It is also used in the treatment of certain autoimmune diseases, such as rheumatoid arthritis and psoriasis.

Dosage Forms: Tacrolimus is available as oral capsules, tablets, and an oral suspension. It is also available as an ointment for topical use in the treatment of eczema.

Dosage and Administration: The dosage of tacrolimus varies depending on the indication, patient’s age, weight, and kidney function. It is usually administered twice daily, with or without food. The dose may need to be adjusted based on therapeutic drug monitoring to maintain a target blood concentration.

Adverse Effects: Common side effects of tacrolimus include tremor, headache, diarrhea, nausea, vomiting, high blood pressure, and increased susceptibility to infections. Long-term use of tacrolimus may increase the risk of developing certain types of cancer, such as skin cancer and lymphoma. It may also cause kidney damage and impair glucose metabolism.

Drug Interactions: Tacrolimus can interact with several medications, including certain antibiotics, antifungals, antivirals, and drugs that affect liver enzymes. These interactions can alter the blood concentration of tacrolimus, leading to toxicity or reduced efficacy. It is important to inform the healthcare provider about all medications being taken.

Monitoring: Regular monitoring of blood levels of tacrolimus is necessary to ensure therapeutic efficacy and prevent toxicity. The target blood concentration may vary depending on the indication and time since transplantation. Other parameters, such as kidney function and blood pressure, should also be monitored regularly.

Contraindications: Tacrolimus is contraindicated in individuals with a hypersensitivity to the drug or any of its components. It should not be used in patients with uncontrolled infections or a history of malignancy, except under careful consideration and close monitoring.

Warnings and Precautions: Tacrolimus should be used with caution in patients with liver or kidney impairment, as well as in those with a history of diabetes or high blood pressure. It may increase the risk of developing opportunistic infections, such as fungal or viral infections. Patients should be advised to avoid prolonged exposure to sunlight and use appropriate sun protection due to an increased risk of skin cancer.

Overall, tacrolimus is an effective immunosuppressant drug used in organ transplantation and autoimmune diseases. However, its use requires careful monitoring and consideration of potential adverse effects and drug interactions.

Test Name IMMUNOSUPPRESSANT DRUG PROFILE 2 Test
Components *Cyclosporine*Sirolimus
Price 1610.0 AED
Sample Condition 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube. Ship refrigerated. Ideal sampling time: Just before the next dose (Trough levels). Provide date & time of sampling, dose taken & time of dosing.
Report Delivery Sample Daily by 5 pm; Report Same day
Method LC-MS/MS
Test type Therapeutic Drug Monitoring
Doctor Gastroenterologist, Nephrologist
Test Department: GENETIC
Pre Test Information Provide date & time of sampling, dose taken & time of dosing.
Test Details

Immunosuppressant drugs are medications that suppress or weaken the immune system. They are commonly used in the treatment of autoimmune diseases, organ transplantation, and certain types of cancer. Here is a profile of a specific immunosuppressant drug:

Drug Name: Tacrolimus (Prograf)

Mechanism of Action: Tacrolimus inhibits the activity of T-lymphocytes, a type of white blood cell involved in the immune response. It works by binding to a protein called FK-binding protein-12 (FKBP-12), which inhibits the activation of calcineurin. This prevents the production of interleukin-2 (IL-2), a cytokine that stimulates T-cell proliferation and activation.

Indications: Tacrolimus is primarily used as an immunosuppressant in organ transplantation, particularly for kidney, liver, and heart transplants. It is also used in the treatment of certain autoimmune diseases, such as rheumatoid arthritis and psoriasis.

Dosage Forms: Tacrolimus is available as oral capsules, tablets, and an oral suspension. It is also available as an ointment for topical use in the treatment of eczema.

Dosage and Administration: The dosage of tacrolimus varies depending on the indication, patient’s age, weight, and kidney function. It is usually administered twice daily, with or without food. The dose may need to be adjusted based on therapeutic drug monitoring to maintain a target blood concentration.

Adverse Effects: Common side effects of tacrolimus include tremor, headache, diarrhea, nausea, vomiting, high blood pressure, and increased susceptibility to infections. Long-term use of tacrolimus may increase the risk of developing certain types of cancer, such as skin cancer and lymphoma. It may also cause kidney damage and impair glucose metabolism.

Drug Interactions: Tacrolimus can interact with several medications, including certain antibiotics, antifungals, antivirals, and drugs that affect liver enzymes. These interactions can alter the blood concentration of tacrolimus, leading to toxicity or reduced efficacy. It is important to inform the healthcare provider about all medications being taken.

Monitoring: Regular monitoring of blood levels of tacrolimus is necessary to ensure therapeutic efficacy and prevent toxicity. The target blood concentration may vary depending on the indication and time since transplantation. Other parameters, such as kidney function and blood pressure, should also be monitored regularly.

Contraindications: Tacrolimus is contraindicated in individuals with a hypersensitivity to the drug or any of its components. It should not be used in patients with uncontrolled infections or a history of malignancy, except under careful consideration and close monitoring.

Warnings and Precautions: Tacrolimus should be used with caution in patients with liver or kidney impairment, as well as in those with a history of diabetes or high blood pressure. It may increase the risk of developing opportunistic infections, such as fungal or viral infections. Patients should be advised to avoid prolonged exposure to sunlight and use appropriate sun protection due to an increased risk of skin cancer.

Overall, tacrolimus is an effective immunosuppressant drug used in organ transplantation and autoimmune diseases. However, its use requires careful monitoring and consideration of potential adverse effects and drug interactions.